15,067 Shares of Tempus AI, Inc. $TEM Acquired by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. bought a new position in Tempus AI, Inc. (NASDAQ:TEM – Free Report) in the 3rd quarter, HoldingsChannel.com reports. The institutional investor bought 15,067 shares of the company’s stock, valued at approximately $1,234,000.

Other large investors have also recently modified their holdings of the company. V Square Quantitative Management LLC purchased a new position in shares of Tempus AI during the third quarter valued at about $27,000. EMC Capital Management bought a new position in Tempus AI in the second quarter worth about $29,000. Ulland Investment Advisors LLC bought a new position in Tempus AI in the third quarter worth about $41,000. Heritage Family Offices LLP bought a new position in Tempus AI in the third quarter worth about $45,000. Finally, Eastern Bank purchased a new stake in Tempus AI in the third quarter worth about $69,000. Institutional investors own 24.22% of the company’s stock.

Insider Buying and Selling at Tempus AI

In related news, CEO Eric Lefkofsky sold 250,000 shares of Tempus AI stock in a transaction dated Tuesday, September 22nd. The shares were sold at an average price of $77.47, for a total transaction of $19,367,500.00. Following the completion of the transaction, the chief executive officer directly owned 100,000 shares of the company’s stock, valued at $7,747,000. This trade represents a 71.43% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO James Rogers sold 26,313 shares of the business’s stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $60.00, for a total transaction of $1,578,780.00. Following the sale, the chief financial officer directly owned 106,024 shares in the company, valued at $6,361,440. The trade was a 19.88% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last 90 days, insiders sold 1,237,227 shares of company stock valued at $85,388,983. Insiders own 24.26% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on TEM shares. Jefferies Financial Group raised Tempus AI from an “underperform” rating to a “hold” rating and lifted their price objective for the company from $35.00 to $70.00 in a research report on Tuesday, November 3rd. Roth Capital assumed coverage on Tempus AI in a report on Tuesday, September 8th. They set a “neutral” rating and a $67.00 target price on the stock. Piper Sandler raised Tempus AI from a “neutral” rating to an “overweight” rating and increased their target price for the stock from $56.00 to $76.00 in a research report on Tuesday, September 1st. Robert W. Baird increased their target price on Tempus AI from $85.00 to $92.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 3rd. Finally, Raymond James Financial set a $80.00 target price on Tempus AI in a research note on Wednesday, September 2nd. Eleven equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $79.37.

Read Our Latest Stock Analysis on TEM

Tempus AI Stock Down 5.7%

Shares of TEM stock traded down $4.29 during mid-day trading on Friday, reaching $71.60. 5,290,976 shares of the company’s stock traded hands, compared to its average volume of 6,460,177. Tempus AI, Inc. has a 12 month low of $40.77 and a 12 month high of $89.09. The company has a market cap of $13.06 billion, a P/E ratio of -67.55 and a beta of 3.61. The company has a quick ratio of 2.48, a current ratio of 2.61 and a debt-to-equity ratio of 2.70. The company’s 50-day moving average price is $72.84 and its 200-day moving average price is $57.54.

Tempus AI (NASDAQ:TEM – Get Free Report) last released its earnings results on Monday, November 2nd. The company reported $0.07 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.16. The firm had revenue of $411.54 million for the quarter, compared to the consensus estimate of $409.39 million. Tempus AI had a negative net margin of 12.54% and a negative return on equity of 47.00%. The company’s revenue was up 23.1% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.46) EPS. On average, equities analysts expect that Tempus AI, Inc. will post -1.20 earnings per share for the current fiscal year.

Tempus AI Profile

(Free Report)

Tempus AI is a technology company focused on applying data and artificial intelligence to healthcare, with an emphasis on precision medicine. Its platform combines clinical and molecular data to help physicians make more informed treatment decisions and support life-sciences research. The company provides genomic sequencing and other diagnostic testing, software tools for analyzing patient data, and services that help identify clinical trial opportunities. Its work spans oncology and other areas of medicine, and it collaborates with healthcare providers and pharmaceutical and biotechnology companies.

Featured Articles

Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM – Free Report).

Institutional Ownership by Quarter for Tempus AI (NASDAQ:TEM)

Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.